| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.997 | 0.001 | 0.997 | Cholinergic | 0.997 0.001 CID_14716289 | ||
| 0.983 | 0 | 0.983 | Acetylcholine M3 receptor agonist | 0.943 0 CID_14716289 | ||
| 0.982 | 0.002 | 0.982 | Nootropic | 0.931 0.003 CID_14716289 | ||
| 0.91 | 0.002 | 0.91 | Acetylcholine agonist | 0.843 0.002 CID_14716289 | ||
| 0.841 | 0 | 0.841 | Acetylcholine M2 receptor agonist | 0.753 0.001 CID_14716289 | ||
| 0.833 | 0.001 | 0.833 | Acetylcholine M1 receptor agonist | 0.795 0.001 CID_14716289 | ||
| 0.83 | 0.001 | 0.83 | Acetylcholine muscarinic agonist | 0.78 0.001 CID_14716289 | ||
| 0.831 | 0.002 | 0.831 | Acetylcholine antagonist | 0.739 0.003 CID_14716289 | ||
| 0.83 | 0.002 | 0.83 | Cholinergic antagonist | 0.737 0.003 CID_14716289 | ||
| 0.816 | 0.002 | 0.816 | Acetylcholine M1 receptor antagonist | 0.446 0.005 CID_14716289 | ||
| 0.746 | 0.002 | 0.746 | Acetylcholine muscarinic antagonist | 0.655 0.003 CID_14716289 | ||
| 0.487 | 0.001 | 0.487 | Acetylcholine M4 receptor agonist | 0.13 0.003 CID_14716289 | ||
| 0.451 | 0.001 | 0.451 | Acetylcholine M5 receptor agonist | 0.191 0.003 CID_14716289 | ||
| 0.418 | 0.002 | 0.418 | Transcription factor NF kappa B stimulant | 0.203 0.009 CID_14716289 | ||
| 0.341 | 0.004 | 0.354 | Acetylcholine M2 receptor antagonist | 0.354 0.004 CID_14716289 | CID_14716289 | |
| 0.258 | 0.013 | 0.258 | 5 Hydroxytryptamine 3E antagonist | 0.241 0.021 CID_14716289 | ||
| 0.184 | 0.028 | 0.184 | 5-Lipoxygenase inhibitor | |||
| 0.21 | 0.107 | 0.21 | DNA synthesis inhibitor | |||
| 0.216 | 0.123 | 0.216 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.189 | 0.118 | 0.189 | RNA-directed DNA polymerase inhibitor | |||
| 0.078 | 0.008 | 0.078 | Somatostatin 5 antagonist | 0.063 0.01 CID_14716289 | ||
| 0.14 | 0.072 | 0.14 | Ca2+-transporting ATPase inhibitor | 0.129 0.125 CID_14716289 | ||
| 0.112 | 0.063 | 0.112 | Mucolytic | 0.097 0.082 CID_14716289 | ||
| 0.075 | 0.031 | 0.075 | 5 Hydroxytryptamine 3 agonist | |||
| 0.064 | 0.02 | 0.064 | Nicotinic receptor alpha4 subunit antagonist | 0.051 0.031 CID_14716289 | ||
| 0.145 | 0.115 | 0.145 | Hepatoprotectant | |||
| 0.059 | 0.03 | 0.059 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.17 | 0.146 | 0.207 | Peptidyltransferase inhibitor | 0.207 0.091 CID_14716289 | CID_14716289 | |
| 0.082 | 0.063 | 0.082 | Antineoplastic alkaloid | |||
| 0.094 | 0.076 | 0.094 | Expectorant | |||
| 0.088 | 0.072 | 0.088 | DNA directed RNA polymerase inhibitor | |||
| 0.096 | 0.08 | 0.096 | 5 Hydroxytryptamine 3A agonist | |||
| 0.074 | 0.062 | 0.074 | Acetylcholine nicotinic antagonist | |||
| 0.075 | 0.064 | 0.075 | Acetylcholine nicotinic agonist | |||
| 0.071 | 0.061 | 0.071 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.06 | 0.054 | 0.06 | Neuronal nicotinic receptor antagonist | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |